Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs directed at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where therapy selections remain limited. Make use of the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/cboe-promotes-cto-tim-lipscomb-to-executive-vice-president/